Personalized medicine for individuals with Down syndrome

Area of Science:

• Genomics
• Personalized Medicine
• Down Syndrome Research

Background:

• Decreasing costs of whole genome analysis enable detailed study of gene-phenotype interactions.
• Current group-based epidemiologic studies may not fully capture individual variability.
• Down syndrome is associated with increased risks of various comorbidities.

Purpose of the Study:

• To apply personalized medicine principles to individuals with Down syndrome.
• To identify biomarkers for predicting comorbidities in Down syndrome.
• To transition from a collective to an individual-centered model of care for Down syndrome.

Main Methods:

• Whole genome analysis to identify genetic variations.
• Biomarker discovery for comorbidity risk assessment.
• Application of personalized medicine frameworks.

Main Results:

• Potential to identify specific gene interactions influencing Down syndrome phenotypes.
• Development of predictive biomarkers for comorbidities.
• Facilitation of individualized treatment strategies.

Conclusions:

• Personalized medicine offers a novel approach to understanding and managing Down syndrome.
• Biomarker development is key to proactive and individualized care.
• This paradigm shift can improve outcomes and alter the "culture of intractability" associated with Down syndrome.